Status:
COMPLETED
Identifying Cancer Genes in in Blood and Bone Marrow Samples From Patients With Acute Myeloid Leukemia
Lead Sponsor:
Alliance for Clinical Trials in Oncology
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Leukemia
Eligibility:
All Genders
Brief Summary
RATIONALE: Studying samples of blood and bone marrow in the laboratory from patients with cancer may help doctors learn more about changes that occur in DNA and identify genes related to cancer. It ma...
Detailed Description
OBJECTIVES: * To identify and validate individual genes for diagnosis of three major translocations in acute myeloid leukemia. * To correlate transcript expression data in the various translocations ...
Eligibility Criteria
Inclusion
- Enrolled on CALGB acute myeloid leukemia (AML) treatment studies AND concurrently enrolled on Leukemia Tissue Bank Protocol CALGB-9665
- Short-term or long-term survivor
- Bone marrow and/or peripheral blood obtained at diagnosis
- Leukemia is one of the following cytogenetic subtypes:
- t(8;21)
- t(15;17)
- inv(16)
Exclusion
Key Trial Info
Start Date :
May 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2014
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT00897182
Start Date
May 1 2008
End Date
March 1 2014
Last Update
July 4 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Fort Wayne Medical Oncology and Hematology
Fort Wayne, Indiana, United States, 46845
2
Wayne Memorial Hospital, Incorporated
Goldsboro, North Carolina, United States, 27534